Hepatic Clearance Differences

Hepatic Clearance Differences is a toxicokinetic construct that refers to interspecies variations in the rate and extent of drug elimination mediated by hepatic processes, primarily distinguished by differences in liver physiology, enzyme expression, and metabolic capacity across species.

146

Publications

7.7K

Citations

726

Authors

217

Institutions

Publications per year

2017–2026

13

Authors

726

  1. YL
    Yurong Lai

    Pfizer (United States), United States

    3 publications · 287 citations

    3

    h-index

  2. LD
    Li Di

    Pfizer (United States), United States

    3 publications · 294 citations

    3

    h-index

  3. AR
    Amin Rostami‐Hodjegan

    University of Manchester, United Kingdom

    3 publications · 329 citations

    3

    h-index

  4. LZ
    Leslie Z. Benet

    University of California, San Francisco, United States

    3 publications · 100 citations

    3

    h-index

  5. GT
    Geoffrey T. Tucker

    University of Sheffield, United Kingdom

    3 publications · 164 citations

    3

    h-index

1–5 of 726

Venues

  1. Drug Metabolism and Disposition

    16 publications · 1.2K citations

    16

    h-index

  2. PubMed

    Repository · 10 publications · 610 citations

    10

    h-index

  3. 9

    h-index

  4. Clinical Pharmacology & Therapeutics

    CPT · 9 publications · 631 citations

    9

    h-index

  5. Xenobiotica

    8 publications · 208 citations

    8

    h-index

1–5